Furthermore, by injecting miR-489 agomir via the tail vein into mice, Jin et al. confirmed that the upregulation of miR-489 had a potential therapeutic effect in silica-induced pulmonary fibrosis, which was related to the inhibition of TGF-β1 release [60]. Here, TGFB1 is linked to pulmonary fibrosis.